Selected article for: "bowel disease and immune response"

Author: Okeke, Francis; Mone, Anjali; Swaminath, Arun
Title: The Course of SARS-COV2 Infection Was Not Severe in a Crohn’s Patient Who Administered Maintenance Anti-TNF Therapy Overlapping the Early Pre-Symptomatic Period of Infection
  • Cord-id: fptdd7qe
  • Document date: 2020_8_15
  • ID: fptdd7qe
    Snippet: The Inflammatory Bowel Disease (IBD) population, which may require treatment with immunosuppressive medications, may be uniquely vulnerable to COVID-19 infection. In fact, there is some evidence these medications may inhibit the cytokine storm that is theorized to cause a rapid decline seen in COVID-19. In addition, the digestive symptoms of COVID-19 can be difficult to distinguish from the activation of IBD. We present an interesting case of a Crohn’s patient inadvertently administering anti-
    Document: The Inflammatory Bowel Disease (IBD) population, which may require treatment with immunosuppressive medications, may be uniquely vulnerable to COVID-19 infection. In fact, there is some evidence these medications may inhibit the cytokine storm that is theorized to cause a rapid decline seen in COVID-19. In addition, the digestive symptoms of COVID-19 can be difficult to distinguish from the activation of IBD. We present an interesting case of a Crohn’s patient inadvertently administering anti-cytokine therapy during the pre-symptomatic period of COVID-19 infection. Immune suppression during early infection with SARS-COV2 risks a poor immune response to the virus and could theoretically result in a more severe course of infection.

    Search related documents:
    Co phrase search for related documents
    • abdominal ct scan and acute respiratory: 1, 2, 3, 4, 5, 6, 7
    • abdominal ct scan and acute respiratory distress syndrome: 1
    • abdominal ct scan and liver function: 1
    • aberrant immune response and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • aberrant immune response and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7
    • abnormal ct scan and acute phase: 1
    • abnormal ct scan and acute respiratory: 1, 2, 3, 4
    • acute phase and additional intervention: 1
    • acute phase and liver function: 1, 2, 3, 4, 5, 6, 7
    • acute phase and lupus erythematosus: 1, 2
    • acute respiratory and additional intervention: 1, 2, 3, 4, 5, 6
    • acute respiratory and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and liver function test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and additional intervention: 1, 2
    • acute respiratory distress syndrome and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute respiratory distress syndrome and liver function test: 1, 2
    • acute respiratory distress syndrome and lupus erythematosus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17